CCA
UTHR icon

Checchi Capital Advisers’s United Therapeutics UTHR Stock Holding History

Checchi Capital Advisers’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-665
Closed -$70K – 1171
2016
Q2 		$70K Buy
665
+10
+2% +$1.11K 0.01% 720
2016
Q1 		$73K Buy
+655
New +$82.9K 0.02% 700

Other funds holding UTHR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Checchi Capital Advisers's UTHR Position: Q3 2016 in Review

Checchi Capital Advisers sold out of United Therapeutics (UTHR) in Q3 2016, closing a stake of 665 shares — an estimated $70K sold.

Checchi Capital Advisers first reported a position in UTHR in Q1 2016 and held it in 2 quarters. The position peaked at $73K in Q1 2016. 394 funds tracked by Wall St. Rank hold UTHR as of Q3 2016.

  • Checchi Capital Advisers reported no remaining United Therapeutics position as of Q3 2016 after selling out during the quarter.
  • Checchi Capital Advisers sold 665 United Therapeutics shares in Q3 2016, an estimated $70K.
  • Checchi Capital Advisers first reported a position in United Therapeutics in Q1 2016 and held it in 2 quarters.
  • Checchi Capital Advisers's United Therapeutics position peaked at $73K in Q1 2016.
  • 394 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2016.

Based on Checchi Capital Advisers's 13F filing for Q3 2016, filed 10 Nov 2016.